Medicines for emerging markets around the world

Every day, more than 64 million people around the world live healthier lives with Abbott’s medicines products. Our portfolio, available in emerging markets only, helps people get and stay healthy through trusted, high-quality medicines.

We focus on women’s health, cardiometabolic conditions, gastroenterology, oncology, immunology and more, with a tailored approach that reflects local needs and delivers accessible, reliable solutions.

We leverage our footprint in emerging countries and scientific heritage to offer more medicines that are superior to available alternatives, backed by strong scientific evidence. Whether it’s an ordinary headache or a more serious illness, we want people to get better fast, so they can go back to doing the things they love.

Related articles

References

1Hichborn J, et al. Improving patient adherence through data-driven insights. McKinsey & Company. 2018. Available at: https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/improving-patient-adherence-through-data-driven-insights

2Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284-290.

3Organisation for Economic Co-operation and Development. OECD Health Working Paper No. 105 Investing in medication adherence improves health outcomes and health system efficiency – Adherence to medicines for diabetes, hypertension, and hyperlipidaemia. 2018. Available at: http://www.Oecd.Org/Officialdocuments/Publicdisplaydocumentpdf/?Cote=DELSA/HEA/WD/HWP(2018)2&Doclanguage=En>

Products and Solutions

Need Help?

© 2026 Abbott. All Rights Reserved. Please read the Legal Notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are approved for use in the U.S. only and are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.